Oyler John

Oyler John is listed in filings as Chief Executive Officer at BeOne Medicines Ltd.. This profile follows SEC Form 4 activity through Jun 15, 2026, including sale activity. Recent filings connect the profile to BeOne Medicines Ltd. (ONC) and BeiGene Ltd (BGNE). The current snapshot covers public activity from Mar 7, 2025 to Jun 15, 2026. Reported amounts are shown as $7.2M to $51.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.